Rockefeller Capital Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$627 Sell
130
-1,343
-91% -$8.11K ﹤0.01% 4576
2026
Q1
$9.07K Sell
1,473
-22,375
-94% -$186K ﹤0.01% 4029
2025
Q4
$248K Buy
23,848
+5,203
+28% +$52.2K ﹤0.01% 2249
2025
Q3
$168K Buy
+18,645
New +$164K ﹤0.01% 2321

Other funds holding RXST

Rockefeller Capital Management's RXST Position: Q2 2026 in Review

Rockefeller Capital Management reduced its RxSight (RXST) stake by 91% in Q2 2026, selling an estimated $8.11K and leaving 130 shares worth $627. The position accounts for ﹤0.01% of the portfolio, ranked #4576.

Rockefeller Capital Management first reported a position in RXST in Q3 2025 and has held it in 4 quarters since. The position peaked at $248K in Q4 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Rockefeller Capital Management held 130 shares of RxSight worth $627 as of Q2 2026.
  • Rockefeller Capital Management sold 1,343 RxSight shares in Q2 2026, an estimated $8.11K.
  • RxSight made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4576 holding.
  • Rockefeller Capital Management first reported a position in RxSight in Q3 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's RxSight position peaked at $248K in Q4 2025.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.